All stock lists
Pasithea Therapeutics Corp. (KTTA)
NASDAQ: KTTA · Real-Time Price · USD
Healthcare · Biotechnology
$0.51+$0.08 (+17.57%)
Insider Score
––Not scored
KTTA Insider Score
Insiders filed in the last 90 days, but none of those trades qualified for scoring — round-trip buys and filings whose price is far off the market are excluded.
KTTA Income Statement
| Fiscal Period | Q2 2026 | Q1 2026 | Q4 2025 | Q3 2025 | Q2 2025 | Q1 2025 |
|---|---|---|---|---|---|---|
| Period Ending | Jun 30, 2026 | Mar 31, 2026 | Dec 31, 2025 | Sep 30, 2025 | Jun 30, 2025 | Mar 31, 2025 |
| Revenue | $0.00 | $0.00 | $0.00 | $0.00 | $0.00 | — |
| Revenue Growth (YoY) | — | — | — | — | — | — |
| Cost of Revenue | — | — | — | — | — | — |
| Gross Profit | — | — | — | — | — | — |
| SG&A Expense | $2.03 M | $1.93 M | $7.51 M | $1.75 M | $1.66 M | — |
| R&D Expense | $3.69 M | $2.94 M | $2.74 M | $1.36 M | $2.15 M | — |
| Operating Expenses | $5.71 M | $4.88 M | $10.26 M | $3.11 M | $3.81 M | — |
| Operating Income | -$5.71 M | -$4.88 M | -$10.26 M | -$3.11 M | -$3.81 M | — |
| Pretax Income | -$5.27 M | -$2.87 M | -$10.11 M | -$3.04 M | -$3.72 M | — |
| Tax Provision | $0.00 | $0.00 | $0.00 | $0.00 | $0.00 | — |
| Net Income | -$5.27 M | -$2.87 M | -$10.11 M | -$3.04 M | -$3.72 M | — |
| EPS (Basic) | -$0.16 | -$0.12 | — | -$0.41 | -$0.66 | -$1.61 |
| EPS (Diluted) | -$0.16 | -$0.12 | — | -$0.41 | -$0.66 | -$1.61 |
| Shares Outstanding | 32.10 M | 24.34 M | — | 7.44 M | 5.64 M | 2.21 M |
Quarterly figures; YoY compares the same fiscal quarter a year earlier. Source: public market data.
Disclaimer — Informational only — not investment advice. Insider transaction data is sourced from SEC Form 4 filings; market data from public feeds and may be delayed. The Insider Score is a proprietary score for research purposes and does not predict future performance. Always do your own research.
